Frazier Life Sciences Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-980,302	Closed	-$11.3M	–	44
2022 Q2	$11.3M	Sell	980,302 -759,228	-44%	-$8.78M	1.07%	25
2022 Q1	$32.2M	Buy	+1,739,530	New	+$32.2M	2.74%	12